SCHEMBL5121235

SCHEMBL5121235

CCOC(=O)C12Cc3ccccc3C(CN(Cc3ccccc3)C1)C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SIGMAR1 Q99720 4/20 0.41
OPRM1 P35372 4/20 0.41
OPRD1 P41143 3/20 0.41
OPRK1 P41145 3/20 0.41
SLC22A1 O15245 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
KCNH2 Q12809 1/20 0.41
GAA P10253 1/20 0.41
LMNA P02545 2/20 0.40
KCNA3 P22001 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14472987 0.90 KDM4E (0.43) KDM4ENPSR1CYP3A4CYP2D6CYP2C9
SCHEMBL4649347 0.88 L3MBTL1 (0.49) KDM4ENPSR1CYP3A4CYP2D6CYP2C9
SCHEMBL5124161 0.87 KDM4E (0.43) KDM4ENPSR1CYP3A4CYP2D6CYP2C9
SCHEMBL4650436 0.86 DRD2 (0.43) KDM4ENPSR1CYP3A4CYP2D6CYP2C9
SCHEMBL13998962 0.84 OPRM1 (0.47) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL5117445 0.83 OPRM1 (0.41) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Hydrochloric Acid SCHEMBL5117451 0.83 OPRM1 (0.48) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL4650544 0.79 MAPT (0.47) KDM4EOPRM1OPRD1OPRK1SLC22A1
SCHEMBL5115949 0.77 ALDH1A1 (0.43) KDM4ECYP2C19GAALMNAMEN1
SCHEMBL14473177 0.76 OPRM1 (0.48) KDM4ENPSR1CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312268-A1 Substituted tricyclic piperidone compounds GRUENENTHAL GMBH (DE) 2008-12-18 US claimed
US-20080312268-A1 Substituted tricyclic piperidone compounds GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed
US-20080312268-A1 Substituted tricyclic piperidone compounds GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed
US-20080312268-A1 Substituted tricyclic piperidone compounds GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312268-A1 Substituted tricyclic piperidone compounds ITCH, OPRD1, OPRK1 KDM4E 2915/4885NPSR1 186/4885CYP3A4 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.